Casein kinase 1: From cell signaling to therapeutic targets in human disease

20 Mar 2025, 9:33

Casein kinase 1: From cell signaling to therapeutic targets in human disease

Dear colleagues, industrial partners and investors,

we would like to attract your attention to the MILESTONE International Conference CK1 protein kinase family: From cell signaling to therapeutic targets in human disease. This, first ever solely CK1-focused conference aims to become a platform to discuss the progress in preclinical development of CK1 inhibitors and degraders.

The conference that will take place in July 21-23, 2025 in Brno, Czech Republic, will bring together world-wide experts from academia and industry working on various aspects of CK1 preclinical and early phase clinical research.

Visit, learn about the invited speakers and register at 🔗 https://ck1.sci.muni.cz/

We warmly invite you to join us and be part of this inspiring scientific gathering.

We are looking to welcome you or your team members in Brno!

Vitezslav Bryja & Konstantinos Tripsianes (local organizers)

Check the website Register to conference Download flyer

Scientific committee

Kathy Gould, Vanderbilt University, USA

Carrie Partch, University of California Santa Cruz, USA

Vítězslav Bryja, Masaryk University, Czech Republic

Pascal Marchand, Nantes University, France

Gopal Sapkota, University of Dundee, UK

Uwe Knippschild, University of Ulm, Germany

Najma Rachidi, Institut Pasteur, France

Konstantinos Tripsianes, Brno, Czech Republic

 

Invited speakers

David Virshup, Duke-NUS, Singapore

Volker Dötsch, Goethe University Frankfurt, Germany

Yinon Ben-Neriah, The Hebrew University of Jerusalem, Israel

David Strutt, University of Sheffield, UK

Stefan Knapp, SGC Frankfurt, Germany

Andrea Venerando, University of Udine, Italy

Lorenzo Pinna, University of Padova, Italy

© 2025
Masaryk University